Source: Υπουργείο Υγείας (CY) Revision Year: 2021 Publisher: MEDOCHEMIE LTD, 1-10 Constantinoupoleos street, 3011 Limassol, Cyprus
Klerimed 250mg film-coated tablet.
Klerimed 500mg film-coated tablet.
| Pharmaceutical Form |
|---|
|
Film coated tablets. 250mg: yellow, oval shaped, convex tablets, scored on one side, film-coated, with dimensions 14 × 8 mm. 500mg: yellow, oval shaped convex tablets film-coated tablets with diameter of nucleus 19.0 × 10.0 mm. |
Each tablet contains 250mg or 500 of clarithromycin.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Clarithromycin |
Clarithromycin is a semi-synthetic derivative of erythromycin A. It exerts its antibacterial action by selectively binding to the 50s ribosomal sub-unit of susceptible bacteria preventing translocation of activated amino acids. It inhibits the intracellular protein synthesis of susceptible bacteria. |
| List of Excipients |
|---|
|
Croscarmellose |
Tablets are packed into PVC/PVDC-Al blisters. Boxes of 14, 16 and 20 tablets.
Not all pack sizes may be marketed.
MEDOCHEMIE LTD, 1-10 Constantinoupoleos street, 3011 Limassol, Cyprus
Klerimed tablets 250 mg: 19927
Klerimed tablets 500 mg: 19195
Klerimed tablets 250 mg: 20.12.2005 / 22.08.2011
Klerimed tablets 500 mg: 29.3.2001 / 28.03.2014
| Drug | Countries | |
|---|---|---|
| KLERIMED | Cyprus, Estonia, Hong Kong, Lithuania, Malta, Romania, Singapore |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
